Last updated: 9 February 2022 at 4:40pm EST

Abraham Oler Net Worth




The estimated Net Worth of Abraham N. Oler is at least $24.5 mil dollars as of 28 January 2022. Mr. Oler owns over 1,500 units of Onconova Therapeutics Inc stock worth over $24,514 and over the last 5 years he sold ONTX stock worth over $0. In addition, he makes $0 as Vice President e Corporate Development and General Counsel at Onconova Therapeutics Inc.

Mr. Oler ONTX stock SEC Form 4 insiders trading

Abraham has made over 11 trades of the Onconova Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 1,500 units of ONTX stock worth $2,505 on 28 January 2022.

The largest trade he's ever made was buying 75,000 units of Onconova Therapeutics Inc stock on 25 November 2019 worth over $15,000. On average, Abraham trades about 9,493 units every 47 days since 2019. As of 28 January 2022 he still owns at least 24,514 units of Onconova Therapeutics Inc stock.

You can see the complete history of Mr. Oler stock trades at the bottom of the page.





Abraham Oler biography

Abraham N. Oler is Vice President, Corporate Development and General Counsel of the company. Mr. Oler served most recently as Vice President of Operations and Chief of Staff to the CEO of Spectrum Pharmaceuticals. During his tenure, he was instrumental in the company's progress and productive licensing activities. He served in varied roles of increasing responsibility, as a member of the executive management team, the corporate development team, and as Head of Alliances and Legal Affairs. Due to a series of successful accomplishments, he was named Chief of Staff.



Insiders trading at Onconova Therapeutics Inc

Over the last 12 years, insiders at Onconova Therapeutics Inc have traded over $1,631,795 worth of Onconova Therapeutics Inc stock and bought 27,892,613 units worth $51,994,589 . The most active insiders traders include Capital, Llc Armistice Capi..., Capital Management, Llc 683, eCapital Partners L P Tyndall. On average, Onconova Therapeutics Inc executives and independent directors trade stock every 40 days with the average trade being worth of $294,478. The most recent stock trade was executed by Mark Patrick Guerin on 13 March 2024, trading 8,666 units of ONTX stock currently worth $8,666.



What does Onconova Therapeutics Inc do?

onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. onconova has three product candidates in clinical trials and six active pre-clinical programs. onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.



What does Onconova Therapeutics Inc's logo look like?

Onconova Therapeutics Inc logo

Complete history of Mr. Oler stock trades at Onconova Therapeutics Inc

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
28 Jan 2022 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 1,500 $1.67 $2,505
28 Jan 2022
24,514
21 Jan 2022 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 1,500 $2.02 $3,030
21 Jan 2022
23,014
14 Jan 2022 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 1,500 $2.20 $3,300
14 Jan 2022
21,514
7 Jan 2022 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 1,500 $2.39 $3,585
7 Jan 2022
20,014
19 Nov 2021 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 1,000 $3.16 $3,160
19 Nov 2021
18,514
28 Sep 2021 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 2,381 $4.20 $10,000
28 Sep 2021
12,515
16 Feb 2021 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 12,000 $1.00 $12,000
16 Feb 2021
152,000
11 Dec 2020 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 30,000 $0.32 $9,600
11 Dec 2020
140,000
25 Nov 2020 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 20,000 $0.26 $5,200
25 Nov 2020
110,000
19 May 2020 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 15,000 $0.37 $5,550
19 May 2020
90,000
25 Nov 2019 Abraham N. Oler
SVP Corp Dev e Gen Counsel
Comprar 75,000 $0.20 $15,000
25 Nov 2019
75,000


Onconova Therapeutics Inc executives and stock owners

Onconova Therapeutics Inc executives and other stock owners filed with the SEC include: